Monitor involuntary movements and tremor
- Trial ID
- NCT06490861
- Official Title
- An Open Multi-centre Investigation to Evaluate the Performance of the Paragit Sleeve With build-in sEMG Sensors, Kinetic Sensors, and Smart-textile to Measure and Monitor Motor Symptoms and Treatment-induced Dyskinesia in Patients With Parkinson's Disease
- Goal
- Monitor involuntary movements and tremor
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Paragit ApS
- Study Type
- INTERVENTIONAL
- Enrollment
- 25 participants
- Conditions
- Parkinson Disease
- Interventions
- Paragit
Plain-Language Summary
The goal is to see whether a wearable smart sleeve can accurately measure and monitor Parkinson's motor symptoms and levodopa-induced dyskinesia, giving clinicians objective data to guide treatment. The Paragit sleeve is a smart-textile you wear on an arm or leg with built-in surface EMG sensors and kinetic motion sensors that record muscle electrical activity and movement patterns to detect rigidity, tremor, bradykinesia, and involuntary dyskinesia, it is a noninvasive monitor that does not change medications but collects data alongside your usual levodopa. The trial seeks adults 50 and older with a clinical Parkinson's diagnosis who experience at least two of those symptoms daily and can give informed consent; people with skin allergies to stainless steel, silicone, or polyester, an MMSE under 24, or other neurological diseases are excluded.
Locations
- Hospital Beata María Ana, Madrid, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Paragit. The goal is to see whether a wearable smart sleeve can accurately measure and monitor Parkinson's motor symptoms and levodopa-induced dyskinesia, giving clinicians objective data to guide treatment. The Paragit sleeve is a smart-textile you wear on an arm or leg with built-in surface EMG sensors and kinetic motion sensors that record muscle electrical activity and movement patterns to detect rigidity, tremor, bradykinesia, and involuntary dyskinesia, it is a noninvasive monitor that does not change medications but collects data alongside your usual levodopa. The trial seeks adults 50 and older with a clinical Parkinson's diagnosis who experience at least two of those symptoms daily and can give informed consent; people with skin allergies to stainless steel, silicone, or polyester, an MMSE under 24, or other neurological diseases are excluded.
- Who can participate?
- Participants must be at least 50 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 7 months.